The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Research Funding - Boehringer Ingelheim; GlaxoSmithKline; Merck Sharp & Dohme; Roche
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) in daily practice: A real-life feasibility analysis at the Medical University Vienna.
 
Barbara Kiesewetter
No Relationships to Disclose
 
Markus Raderer
Honoraria - Celgene; Eisai; Ipsen; Novartis; Roche
 
Guenther G. Steger
Honoraria - Acraf; Amgen; AstraZeneca; Boehringer Ingelheim; Cephalon; Lilly; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Acraf; Amgen; AstraZeneca; Boehringer Ingelheim; Cephalon; Lilly; Novartis; Pfizer; Roche; Teva
Travel, Accommodations, Expenses - Acraf; Amgen; AstraZeneca; Boehringer Ingelheim; Cephalon; Lilly; Novartis; Pfizer; Roche; Teva
 
Rupert Bartsch
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Robert Pirker
Consulting or Advisory Role - Merck Sharp & Dohme; Synta
Speakers' Bureau - Boehringer Ingelheim; Lilly; Pierre Fabre; Roche
 
Sabine Zochbauer-Muller
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Roche
 
Gerald W. Prager
Honoraria - Amgen; Bayer; Celgene; Lilly; Merck Serono; Roche; Sanofi; SERVIER
 
Michael Krainer
No Relationships to Disclose
 
Matthias Preusser
No Relationships to Disclose
 
Manuela Schmidinger
Honoraria - Astellas Oncology; Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer; Roche
 
Thorsten Fuereder
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Sandoz
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Sandoz
 
Christine Marosi
Research Funding - Roche
 
Gottfried J. Locker
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - Pierre Fabre
 
Thomas Brodowicz
Honoraria - Amgen; Bayer; Eisai; Novartis; PharmaMar; Roche
Consulting or Advisory Role - Amgen; Bayer; Eisai; Novartis
Travel, Accommodations, Expenses - PharmaMar
 
Christoph Zielinski
Honoraria - ARIAD; AstraZeneca; Bristol-Myers Squibb; Imugene; Merck Sharp & Dohme; Novartis; Roche